Salik Nazir
Overview
Explore the profile of Salik Nazir including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
135
Citations
438
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chakan M, Mir R, Nazir S, Mohi U Din M, Simnani S, Masood S
Environ Geochem Health
. 2024 Aug;
46(9):359.
PMID: 39093343
This study investigates the radon concentration in groundwater in Kupwara, the northernmost district of the Kashmir valley. It further assesses the annual effective dose experienced by the district's diverse population-infants,...
2.
Minhas A, Wyand R, Ariss R, Nazir S, Jain V, Al-Kindi S, et al.
JACC Adv
. 2024 Jun;
1(2):100030.
PMID: 38939311
No abstract available.
3.
Cash A, Minhas A, Pasadyn V, Nazir S, Ariss R, Gupta R
Am Heart J Plus
. 2024 Apr;
13:100103.
PMID: 38560063
Introduction: Acute pulmonary embolism (PE) is a major cause of mortality in the United States. Recent reports indicate that PE-related mortality rates have increased among individuals younger than 65 years...
4.
Sagheer S, Minhas A, Zaidi S, Shah I, Ahuja K, Ahuja S, et al.
J Card Fail
. 2023 Jul;
29(11):1531-1538.
PMID: 37419409
Background: With the advancement in device technology, the use of durable left ventricular assist devices (LVADs) has increased significantly in recent years. However, there is a dearth of evidence to...
5.
Vyas R, Nazir S, Ahuja K, Minhas A, Elzanaty A, Mir T, et al.
Cardiology
. 2023 May;
148(3):289-292.
PMID: 37231865
Background: Outcomes of patients with hypertrophic cardiomyopathy (HCM) following transcatheter aortic valve replacement (TAVR) remain largely unknown. Objectives: This study sought to assess the clinical characteristics and outcomes of HCM...
6.
Jain V, Minhas A, Ariss R, Nazir S, Khan S, Khan M, et al.
Am J Med
. 2023 May;
136(7):659-668.e7.
PMID: 37183138
Objective: The purpose of this research was to study the contemporary trends in cardiovascular disease (CVD) and diabetes mellitus (DM)-related mortality. Methods: We used the Centers for Disease Control and...
7.
Oral factor Xa inhibitor underutilization following lower extremity peripheral vascular intervention
Bhuta S, Ariss R, Ding L, Nazir S, Magee G, Garg P, et al.
J Vasc Surg
. 2023 Apr;
78(2):498-505.e1.
PMID: 37100234
Objective: Patients undergoing peripheral vascular intervention (PVI) (ie, endovascular revascularization) for symptomatic lower extremity peripheral artery disease remain at high risk for major adverse limb and cardiovascular events. High-quality evidence...
8.
Narendrula A, Minhas A, Issa R, Ariss R, Nazir S, Jain V, et al.
Am J Med Sci
. 2023 Feb;
365(5):470-471.
PMID: 36828122
No abstract available.
9.
Issa R, Minhas A, Issa R, Ariss R, Nazir S, Satti D, et al.
Curr Probl Cardiol
. 2023 Feb;
48(6):101623.
PMID: 36731687
As rural-urban pulmonary hypertension (PH)-related mortality trends have not been reported past 2011, it is important to update the literature to provide guidance for necessary initiatives geared at minimizing barriers...
10.
Issa R, Nazir S, Minhas A, Lang J, Ariss R, Kayani W, et al.
Vasc Med
. 2023 Jan;
28(3):205-213.
PMID: 36597656
Introduction: Peripheral artery disease (PAD) is a common progressive atherosclerotic disease associated with significant morbidity and mortality in the US; however, data regarding PAD-related mortality trends are limited. This study...